Cancer tissues are comprised of various components including tumor cells and the surrounding tumor stroma, which consists of the extracellular matrix and inflammatory cells. Since the tumor stroma plays critical roles in tumor development, investigation of the tumor stroma in addition to tumor cells is important to identify useful tumor-associated markers. To discover novel and useful sero-diagnostic markers, a comparative study of tumor-associated autoantibodies (AAbs) in sera from lung adenocarcinoma (AC) patients was investigated by two-dimensional immunoblotting with AC cell lines or each autologous AC tissues. Autoantigens identified from tissue and cell line samples comprised 58 (45 antigens) and 53 spots (41 antigens), respectively. Thirty-six proteins including Transforming growth factor-beta-induced protein ig-h3 (BIGH3) and Hyaluronan and proteoglycan link protein 1 (HAPLN1) were detected only from tissues, 32 proteins only from cell lines, and 9 proteins from both. BIGH3 and HAPLN1 expressions were confirmed in the tumor stroma, but not in AC cell lines by immunostaining and immunoblotting. These data suggest that autologous tumor tissue and serum are important to coincidently detect AAbs derived from the tumor stroma in addition to tumor cells.
chased from the RIKEN BioResource Center. The N231 cells derived from a small cell lung carcinoma (SCLC) were purchased from the American Type Culture Collection (Rockville, MD, USA). LCN1 cells derived from a large cell neuroendocrine carcinoma (LCNEC) were established in our laboratory (11) . These cells were maintained in RPMI-1640 medium (SIGMA, Steinheim, Germany) supplemented with 10% fetal bovine serum (FBS; Biowest, Miami, FL, USA), 100 units/mL of penicillin, and 100 μg/mL of streptomycin (GIBCO, Auckland, New Zealand). After harvesting and washing twice with phosphate-buffered saline without divalent ions (PBS−), cells were stored at −80°C for proteomic analysis or fixed in 10% formalin and embedded in paraffin for immunohistochemistry.
Tissue and serum samples. Three samples each of pulmonary ACs and their sera were obtained from Kitasato University Hospital. The patients comprised 1 male and 2 females, with a mean age of 66.3 ± 4.03 years. These samples were kept at −80°C until use for proteomic analysis. A part of the tissues was fixed in 10% formalin and embedded in paraffin for immunohistochemistry. All samples were collected in accordance with the ethical guidelines and written consent mandated, and this study was approved by the Ethics Committee of Kitasato University School of Medicine (B07-06). All patients were approached based on approved ethical guidelines, and all agreed to participate in this study and provided written consent. Patients could refuse entry and discontinue participation at any time.
Antibodies. All antibodies used in this study are commercially available. Detailed information on these antibodies is listed in Table 1 .
Sample preparation for proteomic analysis. Twenty milligrams each of 3 minced lung AC tissues and two lung AC cell lines (A549 and LC-2/ad) were briefly sonicated with a lysis buffer containing 7 M urea, 2 M thiourea, 2% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate, 10 mM tris (2-carboxyethyl)-phosphine hydrochloride, 2.5% pharmalyte pH 3-10 for isoelectric focusing (GE Healthcare Bio-Sciences, Piscataway, NJ, USA), and complete mini EDTA-free protease inhibitors (Roche Diagnostics GmbH, Mannheim, Germany) using an ultrasonic homogenizer (VP-050; TAITEC, Aichi, Japan). After centrifugation at 20,000 × g for 5 min at 4°C, the supernatant was alkylated with 1/20 volumes of 400 mM 4-vinylpyridine for 1 h by mixing.
of AAbs have focused on tumor cells. Takashima et al. reported proteomic analysis of AAbs in patients with hepatocellular carcinoma using autologous tissues and sera, but did not focus on AAbs derived from a tumor-associated stroma (28) . Solid tumors are composed of neoplastic cells and surrounding tumor-associated stroma, and the latter is essential for the survival and proliferation of tumor cells (10) . The invasion of cancer cells into surrounding tissues is the hallmark of malignancy, and the invasion process is associated with the marked destruction and regeneration of stromal elements, composed of inflammatory cells, including lymphocytes, granulocytes, and macrophages, vascular endothelial cells and pericytes, and fibroblasts (9) . Because most patients with lung cancer are at an advanced stage at the time of diagnosis, surgically complete resection is accepted in only one in three of these patients. Identification of tumors in earlier stages is thus a top priority, and efforts such as computed tomography have been made over the last decade (12) . Furthermore, Mazzone et al. suggested that blood and breath tests should also be included for lung cancer screening, considering their simplicity and low risk (19) . Currently, the establishment of reliable early diagnosis using biological fluids, such as serum, plasma, and urine, is one of the most challenging aspects of proteomic research (30) . However, there are a few established clinical markers correlated with the response to treatment and prognosis in patients with non-small cell lung cancer. In this study, a comparative investigation of tumor-associated AAbs in sera from pulmonary adenocarcinoma (AC) patients was performed employing two-dimensional gel electrophoresis and immunoblotting with AC-derived cell lines or each autologous AC tissue. Four autoantigens, detected only from AC tissues, were investigated because of their extra-cellular localization and their commercially available antibodies (10, 16, 17, 24) . To confirm whether their expressions are restricted to tumor stromal components, we performed immunohistochemistry and immunoblotting with AC cell lines and AC tissues.
MATERIALS AND METHODS
Cell lines. The A549 and LC-2/ad cells derived from lung AC were purchased from the Japanese Cancer Research Resources Bank (Tokyo, Japan) and the RIKEN BioResource Center (Ibaraki, Japan), respectively. The RERF-LC-AI cells derived from a lung squamous cell carcinoma (SCC) were pur- 
Two-dimensional gel electrophoresis-immunoblotting.
Two-dimensional gel electrophoresis was performed as described previously (18) . A first-dimensional isoelectric focusing gel (100 mm in length and 3 mm in inner diameter) was made with pharmalyte pH 3-10 for IEF. For IEF analysis, 100 μg of extracted protein samples were applied at the cathodic end of the agarose IEF gel, and loaded in 300 V for 5 h at 4°C. After first-dimensional agarose IEF, the IEF gels were equilibrated for 15 min in an equilibration buffer containing 0.05 M Tris-HCl pH 6.5, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.02% bromophenol blue. For the second-dimension, the agarose gels were placed on the top of the seconddimensional 10% SDS polyacrylamide gels and loaded with a constant current at 20 mA per gel. Two pieces of gel were prepared for each sample, one was transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA) for immunoblotting, and the other was visualized by coomassie brilliant blue R-350 (CBB; PhastGel Blue R, GE Healthcare, Uppasla, Sweden) staining.
Blotting membranes were blocked with 0.05% casein/TBS (0.01 M Tris-HCl pH 7.5, 150 mM NaCl) for 30 min at room temperature (RT). The membranes were then reacted with 100-times diluted serum obtained from the matched patient with 0.0025% casein/TBS containing 0.1% Tween 20 (TBS-T) for 1 h at RT. Then, the membranes were incubated with 1,000-times diluted horseradish peroxidase (HRP)-conjugated rabbit anti-human IgG polyclonal antibody (Dako, Glostrup, Denmark) for 30 min at RT. Finally, signals were developed by stable DAB solution (Invitrogen, Carlsbad, CA, USA) for 15 min.
In-gel digestion. The protein spots that reacted with sera were excised and minced to 1 mm 3 from CBBstained 2-dimensional electrophoresis gels, destained with 50% acetonitrile/50 mM NH 4 HCO 3 , dehydrated with 100% acetonitrile, and dried under vacuum conditions. Tryptic digestion was performed with a minimal volume of digestion solution which contained 20 ng/μL trypsin (Trypsin Gold, Mass Spectrometry Grade; Promega, Madison, WI, USA) and 25 mM NH 4 HCO 3 for 24 h at 37°C. After incubation, digested peptide fragments eluted in solutions were collected, and gels were washed once with 5% trifluoroacetic acid/50% acetonitrile and collected in the same tube.
Protein identification. The collected peptide fragments were analyzed using autoflex III matrix-associated laser desorption/ionization-time of flight/time of flight mass spectrometry (MALDI-TOF/TOF MS; Bruker Daltonik, Bremen, Germany). A prespotted AnchorChip 96 set for Proteomics which spotted an α-cyano-4-hydroxycinnamic acid matrix for samples and PAC Peptide Calibstandard for calibration (Bruker Daltonik) was used. Peptide mass fingerprints were measured, and then a few obtained peaks were further measured for their tandem mass spectra as parent masses. Spectra were analyzed using FlexAnalysis software (version 3.0, Bruker Daltonic). Identification of protein was performed by MASCOT (http://www.matrixscience.com) using the IPI Human database (93,289 sequences; 36,994,704 residues), released on 3 May, 2011 (http://www.matrixscience. com), to determine proteins from peptide mass fingerprints and tandem mass data. The following parameters were used for the database search: mass tolerance of 100 ppm and fragment mass tolerance their sera. On the other hand, in the same way as with lung AC cells, a total of 41 antigens in 53 protein spots, were identified. As summarized in Fig. 2 and Tables 2, 3 and 4, 36 proteins including ANXA2,  BIGH3 , CAPG, and HAPLN1 were detected only in lung AC tissues (Table 2) , 32 proteins only in cell lines (Table 3) , and 9 proteins in both (Table 4) .
Immunohistochemical localization of ANXA2, BIGH3, CAPG, and HAPLN1 in lung AC tissues
To confirm the localization of 4 autoantigens (ANXA2, BIGH3, CAPG, and HAPLN1), we immunohistochemically stained the same lung AC tissues as used for 2DE-IB. Tumor cells showed intense membranous and/or cytoplasmic ANXA2 staining, while the staining of stromal fibroblasts was weak (Fig. 3A) . BIGH3 localized in the extra-cellular matrix surrounding tumor nest, but was absent in tumor cells (Fig. 3B ). For CAPG, tumor stromal fibroblasts and macrophages showed intense cytoplasmic staining, while tumor cells showed only weak cytoplasmic staining (Fig. 3C) . The staining of HAPLN1 was intense in infiltrated lymphocytes, but was weak in tumor cells (Fig. 3D ).
Immunoblot analysis with lung AC tissues and cells
To confirm whether ANXA2, CAPG, HAPLN1, and BIGH3 are specifically expressed in each lung AC tissue, we performed IB using 5 cell lines derived from lung carcinomas, and the same 3 AC tissues used for two-dimensional gel electrophoresis-immunoblotting. In the cell lines, the expressions of ANXA2 and CAPG were detected only in ACderived A549 and LC-2/ad cells and SCC-derived RERF-LC-AI cells, but no expression was observed in SCLC-derived N231 cells and LCNEC-derived LCN1 cells (Fig. 4A, B) . HAPLN1 was weakly expressed in LC-2/ad and RERF-LC-AI cells (Fig. 4C) . No BIGH3 expression was detected in any cell lines used (Fig. 4D) . In the AC tissues in which each AAbs was identified, the expression of 4 each autoantigens was variously observed in tumor cells and non-cancerous peripheral lung tissues. The expression levels of HAPLN1 and CAPG were higher in tumor tissues than in normal counterparts ( Fig. 4E-H) . From these results, the expressions of BIGH3 and HAPLN1 were identified in each AC tissue, but not in any cell lines.
DISCUSSION
Among the total of 86 antigenic proteins acquired in this study, BIGH3 and HAPLN1 were localized in set to 0.8 Da; fixed variable chemical modification, oxidation of methionines and pyridylethyl of cysteine.
Immunohistochemistry. Three-micrometer-thick of 10% formalin-fixed and paraffin-embedded cell lines and tissues were deparaffinized in xylene and rehydrated through a descending ethanol series, and then endogenous peroxidase was blocked with 3% hydrogen peroxide for 20 min. Antigens were retrieved by autoclaving in 0.01 mol/L citrate buffer (pH 6.0) with 0.1% Tween 20 at 121°C for 10 min. After being blocked with 0.5% casein/TBS for ANXA2, BIGH3 and CAPG, and with 2% normal swine serum/TBS for HAPLN1 for 10 min each, the sections were reacted with the first antibodies for 17 h at RT. After rinsing in TBS three times for 5 min each, the sections were reacted with ChemMate ENVISION reagent (Dako) for 30 min at RT. Finally, the sections were visualized with Stable DAB solution (Invitrogen) and counterstained with Mayer's hematoxylin.
One-dimensional-immunoblotting. Proteins were extracted from the five lung cancer cell lines and three surgically resected lung cancer tissues with detergent lysis buffer (14) using an ultra-sonic homogenizer. Ten micrograms each of extracted proteins were boiled and separated by SDS-PAGE with 10% polyacrylamide gel with a constant current at 20 mA. The details of the immunoblotting methods are the same as mentioned in the section of two-dimensional gel electrophoresis-immunoblotting. In brief, after blocking with 0.5% casein/TBS for 30 min at RT, the membranes were reacted with anti-ANXA2, -BIGH3, -CAPG, and -HAPLN1 antibodies for 1 h at RT, and then incubated with 1,000-times diluted HRP-conjugated rabbit anti-mouse IgG polyclonal antibody (Dako) for ANXA2 and HRP-conjugated goat anti-rabbit IgG polyclonal antibody (Dako) for the others for 30 min each at RT. Finally, signals were developed using Immobilon Western Chemiluminescent HRP Substrate (Millipore).
RESULTS

Autoantigens identified by two-dimensional gel electrophoresis-immunoblotting
Autoantibodies in lung AC sera assessed by the immunoblotting using lung AC tissues or AC cells that reacted with proteins to become visualized in brown are shown in Fig. 1 . MALDI-TOF/TOF MS analysis identified total 45 antigens from 58 protein spots obtained by two-dimensional gel electrophoresis-immunoblotting with autologous lung AC tissues and (21) . This method is based on the antibody array, and native protein extracts from cancer cells, tissues, and body fluids reversely react with antibodies in a solid state. However, the weak point of this method under the present conditions is the limited numbers of antibodies that can be applied.
In the present study, we used a combination of two-dimensional gel electrophoresis, immunoblotting, and mass spectrometry to identify antigenic proteins that received tumor-specific post-translational modifications and/or protein isoforms using AAbs in the patient's sera. Such two-dimensional gel electrophoresis-based methods have been applied in studies of various cancers, such as lung cancer, breast cancer, renal cell carcinoma, and neuroblastoma (13, 22, 25, 30 (27) . SEREX was first employed to identify tumor-associated antigens by screening with patients' sera against a cDNA expression library obtained from a patient's tissues (29) . Although this method facilitates the large-scale screening of various cancers, it cannot predict tumor-specific post-translational modifications. Phage display and 2D-immunoaffinity chromatography also have the same demerit as SEREX. Because protein microarray targeting finding of AAbs or tumor-associated antigens is possible for high-throughput and large-scale analyses, it is a powerful tool for immunological screening in cancer patients (13) . In this method, recombinant proteins, synthetic peptides, or fractionated and purified proteins from tumor tissues or cancer cells are spotted systematically onto a levels in Caco-2 cells. In accordance with their results, most of the identified autoantigens from lung AC tissues or AC cell lines also did not overlap in the present study (Fig. 2) . BIGH3 was only detected in tissues by immunohistochemistry and immunoblotting (Figs. 3, 4) . Furthermore, Gaggioli et al. (7) reported the importance of tumor-associated fibroblasts surrounding tumor nests, since co-cultures of carcinoma cells and stromal fibroblasts showed that the leading cell is always a fibroblast and that carcinoma cells move within tracks in the extracellular matrix behind the fibroblast. Because, mesenchymal cells such as fibroblasts are capable of remodeling matrix and promoting tumor progression, it is very important to detect the AAbs for molecules derived from fibroblasts in the early stages. In addition, shed light on the mechanisms of tumor-stroma interaction and could be useful for early diagnosis (23) . However, few studies have combined autologous tumor tissues and their sera to find novel tumor markers. The present study clearly demonstrated that autoantigens reacting with AAbs in sera from patients with lung AC markedly differ depending on the kind of protein loaded on two-dimensional gel electrophoresis.
Lenaerts et al. (15) performed comparative proteome analysis by two-dimensional gel electrophoresis and MALDI-TOF MS combination methods using human colon AC cell lines and normal human small and large intestinal epithelium. They found several highly abundant proteins in normal human small intestinal epithelium, but no or low expression Lokman et al. (16) reported that the interaction between ANXA2 and tissue plasminogen activator mediates the conversion of plasminogen to plasmin, which facilitates ECM degradation and the activation of metalloproteases, leading to enhanced tumor cell migration and invasion. Although there was no direct evidence supporting a correlation between CAPG and HAPLN1 and tumor invasion and metastasis (10), and both the autoantigens were localized in non-neoplastic elements surrounding tumor cells in the present study, these two molecules should be further studied to assess their utility as early, useful sero-diagnostic markers. Our data suggest that studies with autologous tumor tissue and serum are important for the detection of AAbs against tumorassociated antigens derived not only from tumor cells but also from the tumor stroma.
